Idorsia’s Quviviq approved for adults with chronic insomnia disorder
The EC’s decision on the insomnia treatment was supported by phase 3 trial results
Read More
Tag: Quviviq
CHMP recommends Idorsia’s dual acting treatment Quviviq for insomnia patients
Quviviq can be used on a long-term basis, addressing a key limitation of existing therapies
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
